In Brief: House methamphetamine bill
This article was originally published in The Tan Sheet
House methamphetamine bill: HR 3852 passes 386-34 on Sept. 26 after being moved from committee discussion to the House floor Sept. 25. Controversy over the House bill is limited to the mandatory minimum sentence provision and the fact that the bill's safe harbor provision includes combination ephedrine products; neither is found in the Senate bill (S 1965). Senate supporters are attempting to "hotline," or pass by unanimous consent, the House version in the time remaining before adjournment. Congress may remain in session as late as Oct. 2...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC